EDITORIAL
Published on 02 Jun 2022
Editorial: Cancer Immunotherapies: From Efficacy to Resistance Mechanisms
doi 10.3389/fimmu.2022.939789
- 1,078 views
- 1 citation
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Cancer Immunotherapies: From Efficacy to Resistance Mechanisms
Cancer Immunotherapies: From Efficacy to Resistance Mechanisms
110k
Total Downloads
356k
Total Views and Downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 16 Nov 2021
Age-Based Disparities in Metastatic Melanoma Patients Treated in the Immune Checkpoint Inhibitors (ICI) Versus Non-ICI Era: A Population-Based Study
doi 10.3389/fimmu.2021.609728
- 2,987 views
- 11 citations
ORIGINAL RESEARCH
Published on 29 Sep 2021
TIGIT Induces (CD3+) T Cell Dysfunction in Colorectal Cancer by Inhibiting Glucose Metabolism
doi 10.3389/fimmu.2021.688961
- 3,538 views
- 24 citations
ORIGINAL RESEARCH
Published on 23 Aug 2021
Clinical Significance and Immunologic Landscape of a Five-IL(R)-Based Signature in Lung Adenocarcinoma
doi 10.3389/fimmu.2021.693062
- 4,108 views
- 14 citations
ORIGINAL RESEARCH
Published on 13 Aug 2021
Immune Infiltrating Cells-Derived Risk Signature Based on Large-scale Analysis Defines Immune Landscape and Predicts Immunotherapy Responses in Glioma Tumor Microenvironment
doi 10.3389/fimmu.2021.691811
- 4,601 views
- 43 citations
SYSTEMATIC REVIEW
Published on 09 Aug 2021
Anti–PD-1 and Anti–PD-L1 in Head and Neck Cancer: A Network Meta-Analysis
doi 10.3389/fimmu.2021.705096
- 14,243 views
- 67 citations
REVIEW
Published on 05 Aug 2021
Inflammasome Signaling: A Novel Paradigm of Hub Platform in Innate Immunity for Cancer Immunology and Immunotherapy
doi 10.3389/fimmu.2021.710110
- 4,020 views
- 8 citations
ORIGINAL RESEARCH
Published on 02 Aug 2021
Preliminary Safety and Potential Effect of 6B11-OCIK Adoptive Cell Therapy Against Platinum-Resistant Recurrent or Refractory Ovarian Cancer
doi 10.3389/fimmu.2021.707468
- 3,206 views
- 4 citations
ORIGINAL RESEARCH
Published on 27 Jul 2021
Combined Blockade of GARP:TGF-β1 and PD-1 Increases Infiltration of T Cells and Density of Pericyte-Covered GARP+ Blood Vessels in Mouse MC38 Tumors
doi 10.3389/fimmu.2021.704050
- 10,828 views
- 12 citations
ORIGINAL RESEARCH
Published on 22 Jul 2021
IDO Inhibition Facilitates Antitumor Immunity of Vγ9Vδ2 T Cells in Triple-Negative Breast Cancer
doi 10.3389/fonc.2021.679517
- 3,537 views
- 22 citations
REVIEW
Published on 21 Jul 2021
Cancer Immunotherapies: From Efficacy to Resistance Mechanisms – Not Only Checkpoint Matters
doi 10.3389/fimmu.2021.690112
- 13,270 views
- 65 citations
ORIGINAL RESEARCH
Published on 08 Jul 2021
Prognostic Impact of Sarcopenia and Radiotherapy in Patients With Advanced Gastric Cancer Treated With Anti-PD-1 Antibody
doi 10.3389/fimmu.2021.701668
- 2,843 views
- 15 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 356kTopic views
- 243kArticle views
- 110kArticle downloads